Bull&Bear | Shimmick and Cassava Lead Gains While Telus and Snap Plummet
Friday, Aug 2, 2024 6:00 pm ET
1min read SAVA --
SHIM --
Rising Stocks:
Shimmick (SHIM) increased by 49.24%, marking a three-day consecutive rise with a 59.87% gain over the last three days. Shimmick's stock surged today due to the company's recognition as one of the ENR 400 top contractors. This accolade underscores Shimmick's strength and reputation in the construction and engineering sectors, boosting investor confidence.
Cassava Sciences (SAVA) rose by 23.93%, continuing a three-day rally with a 65.68% gain over the last three days. Cassava Sciences is slated to hold a conference call on August 8, 2024, at 8:30 AM ET to discuss the latest developments and provide a company update.
Tandem Diabetes Care (TNDM) surged by 18.35%. Tandem Diabetes Care's stock climbed following an impressive Q2 performance and an optimistic sales forecast for 2024.
Standard BioTools (LAB) advanced by 16.20%. Despite TD Cowen maintaining a buy rating for Standard BioTools, the target price was revised downward to $2.75.
Cerus (CERS) increased by 14.95%. Cerus is strongly recommended for purchase due to its robust revenue growth and market expansion.
Declining Stocks:
Telus International (TIXT) plummeted by 35.96%, suffering a two-day decline with a 38.61% drop over the past two days. U.S. small-cap stocks fell, with Telus International taking the hardest hit.
Snap (SNAP) dropped by 26.93%, continuing a two-day decline with a 29.73% loss over the last two days. Snap's brand performance lagged expectations, sparking significant market discussion.
Intel (INTC) fell by 26.06%, marking a two-day losing streak with a 30.12% drop over the last two days. Intel reported disappointing Q2 results and guidance, falling well short of expectations. The company announced plans to cut over 15% of its workforce and pause dividend payments.
Gyre Therapeutics (GYRE) declined by 22.76%, extending a two-day slide with a 25.43% drop over the last two days. A Gyre Therapeutics board member sold 3,452 shares of common stock, valued at approximately $41,400.
Xponential Fitness (XPOF) dropped by 22.90%, posting a four-day losing streak with a 26.61% decline over the past four days. Unexpected losses led to a 30.6% nosedive in Xponential Fitness's stock price.
Shimmick (SHIM) increased by 49.24%, marking a three-day consecutive rise with a 59.87% gain over the last three days. Shimmick's stock surged today due to the company's recognition as one of the ENR 400 top contractors. This accolade underscores Shimmick's strength and reputation in the construction and engineering sectors, boosting investor confidence.
Cassava Sciences (SAVA) rose by 23.93%, continuing a three-day rally with a 65.68% gain over the last three days. Cassava Sciences is slated to hold a conference call on August 8, 2024, at 8:30 AM ET to discuss the latest developments and provide a company update.
Tandem Diabetes Care (TNDM) surged by 18.35%. Tandem Diabetes Care's stock climbed following an impressive Q2 performance and an optimistic sales forecast for 2024.
Standard BioTools (LAB) advanced by 16.20%. Despite TD Cowen maintaining a buy rating for Standard BioTools, the target price was revised downward to $2.75.
Cerus (CERS) increased by 14.95%. Cerus is strongly recommended for purchase due to its robust revenue growth and market expansion.
Declining Stocks:
Telus International (TIXT) plummeted by 35.96%, suffering a two-day decline with a 38.61% drop over the past two days. U.S. small-cap stocks fell, with Telus International taking the hardest hit.
Snap (SNAP) dropped by 26.93%, continuing a two-day decline with a 29.73% loss over the last two days. Snap's brand performance lagged expectations, sparking significant market discussion.
Intel (INTC) fell by 26.06%, marking a two-day losing streak with a 30.12% drop over the last two days. Intel reported disappointing Q2 results and guidance, falling well short of expectations. The company announced plans to cut over 15% of its workforce and pause dividend payments.
Gyre Therapeutics (GYRE) declined by 22.76%, extending a two-day slide with a 25.43% drop over the last two days. A Gyre Therapeutics board member sold 3,452 shares of common stock, valued at approximately $41,400.
Xponential Fitness (XPOF) dropped by 22.90%, posting a four-day losing streak with a 26.61% decline over the past four days. Unexpected losses led to a 30.6% nosedive in Xponential Fitness's stock price.